Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Feb 8, 2011

Premium

BioNanomatrix has named Erik Holmlin as its president, CEO, and director. Holmlin succeeds Edward Erickson, who led the company since December 2009.

Prior to joining BioNanomatrix, Holmlin was president and CEO of GenVault, which merged with Integenx last month. Previously, Holmlin served as chief commercial officer at Exiqon. He was also a founder of GeneOhm Sciences, which was acquired by Becton Dickinson in 2006.


Microarrays Inc. has appointed Andrew Jennings as its president of business development. Prior to joining MI, Jennings led the sales organization for Open Biosystems, now Thermo Fisher Scientific, for five years.

The Scan

Single-Cell Sequencing Points to Embryo Mosaicism

Mosaicism may affect preimplantation genetic tests for aneuploidy, a single-cell sequencing-based analysis of almost three dozen embryos in PLOS Genetics finds.

Rett Syndrome Mouse Model Study Points to RNA Editing Possibilities

Investigators targeted MECP2 in mutant mouse models of Rett syndrome, showing in PNAS that they could restore its expression and dial down symptoms.

Investigators Find Shared, Distinct Genetic Contributors to Childhood Hodgkin Lymphoma

An association study in JAMA Network Open uncovers risk variants within and beyond the human leukocyte antigen locus.

Transcriptomic, Epigenetic Study Appears to Explain Anti-Viral Effects of TB Vaccine

Researchers report in Science Advances on an interferon signature and long-term shifts in monocyte cell DNA methylation in Bacille Calmette-Guérin-vaccinated infant samples.